Virginia Retirement Systems Et Al Biocryst Pharmaceuticals Inc Transaction History
Virginia Retirement Systems Et Al
- $15 Billion
- Q3 2025
A detailed history of Virginia Retirement Systems Et Al transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 113,004 shares of BCRX stock, worth $800,068. This represents 0.01% of its overall portfolio holdings.
Number of Shares
113,004
Previous 83,704
35.0%
Holding current value
$800,068
Previous $749,000
14.42%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding BCRX
# of Institutions
308Shares Held
198MCall Options Held
640KPut Options Held
507K-
Vanguard Group Inc Valley Forge, PA21.8MShares$154 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$141 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY12.2MShares$86.2 Million1.72% of portfolio
-
State Street Corp Boston, MA9.81MShares$69.4 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.39MShares$66.5 Million6.02% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.32B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...